Skip to main content
. 2011 Fall;7(3):123–128.

Table 2.

The comparison of participants’ sign and symptoms and the method of treatment between two groups

Variable Total n(%) First DVT n(%) Recurrent DVT n(%) P value
Site 0.867††
 Left Leg 229 (59.48) 202 (59.94) 27 (56.25)
 Right Leg 143 (37.14) 124 (36.79) 19 (39.58)
 Both 13 (3.37) 11 (3.26) 2 (4.16)
Swelling 374(97.1) 331(98.2) 43(89.6) 0.006††
pain 326(84.7) 288(85.5) 38(79.2) 0.117††
Tenderness 116(30.1) 98(29.1) 18(37.5) 0.234††
Warmness 180(46.8) 163(48.4) 17(35.4) 0.092††
Erythema 93(24.2) 77(22.8) 16(33.3) 0.112††
Bulging 6(1.6) 4(1.2) 2(4.2) 0.165††
fever 27(7.0) 26(7.7) 1(2.1) 0.227††
treatment
 Heparin + warfarin 318(82.6) 275(81.6) 43(89.6) 0.642††
 Heparin 22(5.7) 20(5.9) 2(4.2)
 Enoxaparin 2(0.5) 2(0.6) 0(0)
 Enoxaparin + warfarin 27(7.0) 24(7.1) 3(6.3)
 Enoxaparin + warfarin + Heparin 16(4.2) 16(4.7) 0(0)
Hospital stay (days) * 7.23 ± 5.48 7.43 ± 5.74 5.77 ± 2.64 0.049

DVT: Deep vein thrombosis

*

Mean ± Standard deviation

Student's t-test

††

Chi-square